Checkpoint inhibitor responses can be regulated by the gut microbiota - A systematic review.

According to Matson et al., who used anti-PD-1 on some patients and anti-CTLA-4 on others, "the downstream data conclusions did not change", so the choice of ICI therapy might not be significant [14] .

also in 673 other papers